Data Factory
Reading the graph
Reading the graph
Venture Capital
White Plains, NY
Founded in 2017 in New York, Forepont Capital Partners is a global asset manager in healthcare and life science.
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
| Fund | Vintage | Lifecycle | Form D sold | GAV | LPs |
|---|---|---|---|---|---|
| Forepont Capital Partners Fund 2, Fpci | 2020 | Mature | n/a | $29.6M | 0 |
| Forepont Capital Partners Fund 2, L.P. | 2020 | Mature | n/a | $47.6M | 0 |
| Company | State | Stage | Round size | Partner | Attribution | Observed |
|---|---|---|---|---|---|---|
| BeCareLink | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Blackrock Neurotech | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| GPN Vaccines, Inc. | De | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Bcv | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| BioSpeedia | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Exceliom | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Precision | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Synchron | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Bay Bridge Digital | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Investor | Co-investor | Shared deals | Shared companies | Last observed | Strength |
|---|---|---|---|---|---|
| Khosla Ventures, LLC | Forepont Capital LLC | 1 | 1 | Sep 16, 2026 | One time |
| Phifund Managers, LLC | Forepont Capital LLC | 1 | 1 | Sep 16, 2026 | One time |
| Arch Venture Partners | Forepont Capital LLC | 1 | 1 | Sep 16, 2026 | One time |
| Forepont Capital LLC | Catalio Capital Management, LP | 1 | 1 | Sep 16, 2026 | One time |
Also named here, with no published line of their own (reach them through the firm): Laurent Bouyoux (Board member), A. Cheikh Lahlou (Senior Advisor), David Putrino (Venture Partner), Doug Weber (Venture Partner), Michel Vounatsos (Senior Advisor), Dr. Philippe Schaison (Board member), Geoff Kalish (Board member), PER Wold-Olsen (Board member), David Norton (Board member), Ismail Kola (Chief Science Officer), Eric Michel Attias (Managing Partner), Bruce Ira Greenberg (Chief Compliance Officer, Chief Financial Officer).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan